Organovo (NASDAQ:ONVO) (NASDAQ:ONVO) is a biotechnology company specializing in three-dimensional (3D) bioprinting technology to create functional human tissues for medical research and therapeutic applications. Founded in 2007 and headquartered in San Diego, California, Organovo develops living tissue models that closely mimic the structure and function of human organs. These tissue models are designed to accelerate drug discovery, reduce animal testing, and support regenerative medicine programs.
The company’s core offering is its proprietary NovoGen Bioprinter platform, which layers living cells and biomaterials to fabricate 3D human tissue structures. Organovo’s exVive Human Liver Tissue is one of its lead commercial products, providing pharmaceutical companies with a tool for assessing drug toxicity and efficacy in a biologically relevant setting. The firm is also advancing research initiatives in oncology, kidney disease and other therapeutic areas by developing tumor models and kidney tissues that support disease modeling and drug screening.
Organovo serves clients in the pharmaceutical, biotechnology and academic research sectors across North America, Europe and Asia. Through collaborations and service agreements, the company partners with leading drug developers and research institutions to customize tissue models for specific programs. Its contract research services include assay development, pathway analysis and long-term tissue maintenance, supporting preclinical and translational research workflows.
The company’s leadership team brings expertise in biotechnology, engineering and clinical research. Organovo is led by Chief Executive Officer Kevin Mills, who has guided the company’s strategic focus on commercial tissue products and partnerships since 2019. The executive team and board of directors feature veteran professionals with backgrounds in drug development, regulatory affairs and biomedical instrumentation, positioning Organovo to advance the adoption of bioprinted tissues in both research and therapeutic contexts.
